Nicolas Pelisch

614 total citations
18 papers, 477 citations indexed

About

Nicolas Pelisch is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Nicolas Pelisch has authored 18 papers receiving a total of 477 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 6 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Molecular Biology. Recurrent topics in Nicolas Pelisch's work include Renin-Angiotensin System Studies (8 papers), Spinal Cord Injury Research (5 papers) and Hormonal Regulation and Hypertension (5 papers). Nicolas Pelisch is often cited by papers focused on Renin-Angiotensin System Studies (8 papers), Spinal Cord Injury Research (5 papers) and Hormonal Regulation and Hypertension (5 papers). Nicolas Pelisch collaborates with scholars based in Japan, United States and Belgium. Nicolas Pelisch's co-authors include Akira Nishiyama, Naohisa Hosomi, Hirofumi Hitomi, Daisuke Nakano, Masakazu Kohno, Antje Kroner, Hiroyuki Kobori, David P. Stirling, Masaki Ueno and Masayasu Matsumoto and has published in prestigious journals such as PLoS ONE, Experimental Neurology and Neurobiology of Disease.

In The Last Decade

Nicolas Pelisch

18 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nicolas Pelisch Japan 14 157 129 99 91 79 18 477
Savitree Thummasorn Thailand 9 138 0.9× 201 1.6× 59 0.6× 93 1.0× 115 1.5× 10 450
Mallikarjuna R. Pabbidi United States 15 161 1.0× 258 2.0× 135 1.4× 90 1.0× 157 2.0× 24 729
Wallaya Jongjaroenprasert Thailand 12 112 0.7× 327 2.5× 94 0.9× 128 1.4× 132 1.7× 22 767
Wenli Sheng China 13 77 0.5× 200 1.6× 69 0.7× 80 0.9× 151 1.9× 39 641
Tsuyoshi Hattori Japan 9 150 1.0× 288 2.2× 47 0.5× 49 0.5× 185 2.3× 27 680
Harumitsu Nagoya Japan 10 85 0.5× 149 1.2× 96 1.0× 21 0.2× 64 0.8× 27 494
Alessandro Landolfi Italy 12 142 0.9× 119 0.9× 99 1.0× 36 0.4× 166 2.1× 16 548
Junlan Yao United States 13 94 0.6× 303 2.3× 101 1.0× 115 1.3× 32 0.4× 21 506
Maha Coucha United States 17 62 0.4× 212 1.6× 246 2.5× 85 0.9× 131 1.7× 33 719
Efrat Shavit‐Stein Israel 18 89 0.6× 249 1.9× 185 1.9× 31 0.3× 68 0.9× 63 910

Countries citing papers authored by Nicolas Pelisch

Since Specialization
Citations

This map shows the geographic impact of Nicolas Pelisch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Pelisch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Pelisch more than expected).

Fields of papers citing papers by Nicolas Pelisch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Pelisch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Pelisch. The network helps show where Nicolas Pelisch may publish in the future.

Co-authorship network of co-authors of Nicolas Pelisch

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Pelisch. A scholar is included among the top collaborators of Nicolas Pelisch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Pelisch. Nicolas Pelisch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Pelisch, Nicolas, et al.. (2021). Use of a Self-Delivering Anti-CCL3 FANA Oligonucleotide as an Innovative Approach to Target Inflammation after Spinal Cord Injury. eNeuro. 8(2). ENEURO.0338–20.2021. 15 indexed citations
2.
Pelisch, Nicolas, et al.. (2020). CCL3 contributes to secondary damage after spinal cord injury. Journal of Neuroinflammation. 17(1). 362–362. 57 indexed citations
3.
Pelisch, Nicolas, et al.. (2017). Differential expression of ryanodine receptor isoforms after spinal cord injury. Neuroscience Letters. 660. 51–56. 11 indexed citations
4.
Pelisch, Nicolas, et al.. (2017). The toll-like receptor 2 agonist Pam3CSK4 is neuroprotective after spinal cord injury. Experimental Neurology. 294. 1–11. 25 indexed citations
5.
Pelisch, Nicolas, et al.. (2017). Intracellular calcium release through IP 3 R or RyR contributes to secondary axonal degeneration. Neurobiology of Disease. 106. 235–243. 22 indexed citations
6.
Hasegawa, Sae, et al.. (2015). A Novel Antidiabetic Therapy: Free Fatty Acid Receptors as Potential Drug Target. Current Diabetes Reviews. 11(2). 107–115. 10 indexed citations
7.
Pelisch, Nicolas, Takashi Dan, Atsuhiko Ichimura, et al.. (2015). Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis. PLoS ONE. 10(4). e0124510–e0124510. 31 indexed citations
8.
Dan, Takashi, et al.. (2014). Plasminogen activator inhibitor-1 (PAI-1) molecule: new physiological roles and clinical applications.. PubMed. 55(4). 396–404. 2 indexed citations
9.
Pelisch, Nicolas, Naohisa Hosomi, Hirohito Mori, Tsutomu Masaki, & Akira Nishiyama. (2013). RAS Inhibition Attenuates Cognitive Impairment by Reducing Blood- Brain Barrier Permeability in Hypertensive Subjects. Current Hypertension Reviews. 9(2). 93–98. 34 indexed citations
10.
Nakano, Daisuke, Nicolas Pelisch, Hirofumi Hitomi, et al.. (2013). Angiotensin-Converting Enzyme Inhibitor Does Not Suppress Renal Angiotensin II Levels in Angiotensin I^|^ndash;Infused Rats. Journal of Pharmacological Sciences. 122(2). 103–108. 4 indexed citations
11.
Kosaka, Shinji, Nicolas Pelisch, Matlubur Rahman, et al.. (2013). Effects of Angiotensin II AT1^|^ndash;Receptor Blockade on High Fat Diet^|^ndash;Induced Vascular Oxidative Stress and Endothelial Dysfunction in Dahl Salt-Sensitive Rats. Journal of Pharmacological Sciences. 121(2). 95–102. 13 indexed citations
12.
Liu, Gang, Naohisa Hosomi, Hirofumi Hitomi, et al.. (2011). Angiotensin II induces human astrocyte senescence through reactive oxygen species production. Hypertension Research. 34(4). 479–483. 30 indexed citations
13.
Fu, Hua, Naohisa Hosomi, Nicolas Pelisch, et al.. (2011). Therapeutic effects of postischemic treatment with hypotensive doses of an angiotensin II receptor blocker on transient focal cerebral ischemia. Journal of Hypertension. 29(11). 2210–2219. 13 indexed citations
14.
Kiyomoto, Hideyasu, Hiroyuki Kobori, Yukiko Nagai, et al.. (2010). Regression of superficial glomerular podocyte injury in type 2 diabetic rats with overt albuminuria: effect of angiotensin II blockade. Journal of Hypertension. 28(11). 2289–2298. 30 indexed citations
15.
Pelisch, Nicolas, Naohisa Hosomi, Masaki Ueno, et al.. (2010). Blockade of AT1 Receptors Protects the Blood-Brain Barrier and Improves Cognition in Dahl Salt-Sensitive Hypertensive Rats. American Journal of Hypertension. 24(3). 362–368. 81 indexed citations
16.
Liu, Gang, Hirofumi Hitomi, Naohisa Hosomi, et al.. (2010). Mechanical stretch potentiates angiotensin II-induced proliferation in spontaneously hypertensive rat vascular smooth muscle cells. Hypertension Research. 33(12). 1250–1257. 19 indexed citations
17.
Nagai, Yukiko, Atsuhiro Ichihara, Daisuke Nakano, et al.. (2009). Possible contribution of the non‐proteolytic activation of prorenin to the development of insulin resistance in fructose‐fed rats. Experimental Physiology. 94(9). 1016–1023. 47 indexed citations
18.
Pelisch, Nicolas, Naohisa Hosomi, Masaki Ueno, et al.. (2009). Systemic candesartan reduces brain angiotensin II via downregulation of brain renin–angiotensin system. Hypertension Research. 33(2). 161–164. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Savitree Thummasorn Breakdown of academic impact, for papers by Mallikarjuna R. Pabbidi Breakdown of academic impact, for papers by Wallaya Jongjaroenprasert Breakdown of academic impact, for papers by Wenli Sheng Breakdown of academic impact, for papers by Tsuyoshi Hattori Breakdown of academic impact, for papers by Harumitsu Nagoya Breakdown of academic impact, for papers by Alessandro Landolfi Breakdown of academic impact, for papers by Junlan Yao Breakdown of academic impact, for papers by Maha Coucha Breakdown of academic impact, for papers by Efrat Shavit‐Stein
Rankless by CCL
2026